drugset / Trial / NCT02177448

BIBR 277 Capsule in Patients With Essential Hypertension

NCT02177448

Phase 3 Completed 225 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The efficacy and safety of Telmisartan capsule in patients with essential hypertension were evaluated in comparison with Enalapril Maleate in the double blind trial.

Timeline

Start
1998-09
Primary completion
1999-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enalapril Other / unclassified
Subject Telmisartan Other / unclassified

Indications